DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Genesys International Corporation Limited — Updates

NSE 3d ago·27 Aug 2026, 5:15 am

GENESYS-RE NSE

Genesys International Corporation Limited has announced the appointment of Dhiman Basu Ray as its new Chief Technology Officer. This move comes as the company updates the stock exchange with details regarding this executive change.

For investors, this appointment is significant because the CTO plays a critical role in driving the company's technological strategy and innovation. A new leader in this position often signals a shift in focus toward digital transformation or operational efficiency, which can impact the company's long-term growth prospects.

Investors should watch for the press release to understand Ray's specific background and the strategic vision he brings to the table. This will help gauge how the company plans to leverage technology to enhance its competitive edge in the market.